TIL (Instil Bio, Inc. Common Stock) Stock Analysis - Analyst Ratings

Instil Bio, Inc. Common Stock (TIL) is a publicly traded Healthcare sector company. As of May 21, 2026, TIL trades at $8.02 with a market cap of $55.14M and a P/E ratio of -0.76. TIL moved +1.25% today. Year to date, TIL is -34.74%; over the trailing twelve months it is -51.22%. Its 52-week range spans $5.67 to $70.16. Rallies surfaces TIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate TIL?

The average price target is $0.00.

TIL Key Metrics

Key financial metrics for TIL
MetricValue
Price$8.02
Market Cap$55.14M
P/E Ratio-0.76
EPS$-10.70
Dividend Yield0.00%
52-Week High$70.16
52-Week Low$5.67
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-71.37M
Gross Margin0.00%

TIL Analyst Consensus

TIL analyst coverage data. Average price target: $0.00.

Latest TIL News

Recent TIL Insider Trades

  • Laumas Sandeep sold 17.54K (~$404.10K) on Sep 10, 2025.
  • Laumas Sandeep sold 12.46K (~$297.57K) on Sep 10, 2025.
  • Vivo Capital IX, LLC bought 300.00K (~$6.00M) on Mar 23, 2021.

Common questions about TIL

What do analysts rate TIL?
The average price target is $0.00.
Does Rallies show TIL price targets?
Yes. Rallies tracks TIL analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is TIL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TIL. It does not provide personalized investment advice.
TIL

TIL